Preclinical evaluation of a 68Ga-labeled biotin analogue for applications in islet transplantation

Nuclear Medicine and Biology

Volumn 39, Issue 3, 2012, Pages 415-421

  Eriksson, Olof ^a   Carlsson, Fredrik ^a   Blom, Elisabeth ^a   Sundin, Anders ^b   Långström, Bengt ^a   Korsgren, Olle ^a   Velikyan, Irina ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Avidin biotin; Islet imaging; Islet transplantation; Pretargeting

Indexed keywords

1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID 2 MACROGOL BIOTIN GA 68; AGAROSE; AVIDIN; BIOTIN; TRACER; UNCLASSIFIED DRUG; AVIDIN AGAROSE; AVIDIN-AGAROSE; DIAGNOSTIC AGENT; DRUG DERIVATIVE; GALLIUM; ORGANOMETALLIC COMPOUND; SEPHAROSE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG RETENTION; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG UPTAKE; EX VIVO STUDY; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PANCREAS ISLET; PANCREAS ISLET TRANSPLANTATION; POSITRON EMISSION TOMOGRAPHY; TISSUE DISTRIBUTION; ANIMAL; BINDING COMPETITION; C57BL MOUSE; CHEMICAL STRUCTURE; CHEMISTRY; EVALUATION; INTRAVENOUS DRUG ADMINISTRATION; METABOLISM; METHODOLOGY; SCINTISCANNING;

ANIMALS; AVIDIN; BINDING, COMPETITIVE; BIOTIN; GALLIUM RADIOISOTOPES; HUMANS; INJECTIONS, INTRAVENOUS; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; MALE; MICE; MICE, INBRED C57BL; MOLECULAR STRUCTURE; ORGANOMETALLIC COMPOUNDS; POSITRON-EMISSION TOMOGRAPHY; SEPHAROSE; TISSUE DISTRIBUTION;

EID: 84858159095     PISSN: 09698051     EISSN: 18729614     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2011.09.009     Document Type: Article

References (25)

1. Lesch H.P., Kaikkonen M.U., Pikkarainen J.T., Yla-Herttuala S. Avidin-biotin technology in targeted therapy. Expert Opin Drug Deliv 2010, 7(5):551-564.
2. Gruaz-Guyon A., Raguin O., Barbet J. Recent advances in pretargeted radioimmunotherapy. Curr Med Chem 2005, 12(3):319-338.
3. Kalofonos H.P., Rusckowski M., Siebecker D.A., Sivolapenko G.B., Snook D., Lavender J.P., et al. Imaging of tumor in patients with indium-111-labeled biotin and streptavidin-conjugated antibodies: preliminary communication. J Nucl Med 1990, 31(11):1791-1796.
4. Lewis M.R., Wang M., Axworthy D.B., Theodore L.J., Mallet R.W., Fritzberg A.R., et al. In vivo evaluation of pretargeted 64Cu for tumor imaging and therapy. J Nucl Med 2003, 44(8):1284-1292.
5. Shoup T.M., Fischman A.J., Jaywook S., Babich J.W., Strauss H.W., Elmaleh D.R. Synthesis of fluorine-18-labeled biotin derivatives: biodistribution and infection localization. J Nucl Med 1994, 35(10):1685-1690.
6. Najafi A., Peterson A. Preparation and in vitro evaluation of ' no-carrier-added' 18F-labeled biotin. Nucl Med Biol 1993, 20(4):401-405.
7. Kudo T., Ueda M., Konishi H., Kawashima H., Kuge Y., Mukai T., et al. PET imaging of hypoxia-inducible factor-1-active tumor cells with pretargeted oxygen-dependent degradable streptavidin and a novel (18)F-labeled biotin derivative. Mol Imaging Biol 2010, 13(5):1003-1010.
8. Blom E., Langstrom B., Velikyan I. 68Ga-labeling of biotin analogues and their characterization. Bioconjug Chem 2009, 20(6):1146-1151.
9. Rosenberg S.A., Restifo N.P., Yang J.C., Morgan R.A., Dudley M.E. Adoptive cell transfer: a clinical path to effective cancer immunotherapy. Nat Rev Cancer 2008, 8(4):299-308.
10. Shapiro A.M., Ricordi C., Hering B.J., Auchincloss H., Lindblad R., Robertson R.P., et al. International trial of the Edmonton protocol for islet transplantation. N Engl J Med 2006, 355(13):1318-1330.
11. Christoffersson G., Henriksnas J., Johansson L., Rolny C., Ahlstrom H., Caballero-Corbalan J., et al. Clinical and experimental pancreatic islet transplantation to striated muscle: establishment of a vascular system similar to that in native islets. Diabetes 2010, 59(10):2569-2578.
12. Merani S., Toso C., Emamaullee J., Shapiro A.M. Optimal implantation site for pancreatic islet transplantation. Br J Surg 2008, 95(12):1449-1461.
13. Korsgren O., Nilsson B. Improving islet transplantation: a road map for a widespread application for the cure of persons with type I diabetes. Curr Opin Organ Transplant 2009, 14(6):683-687.
14. Witkowski P., Sondermeijer H., Hardy M.A., Woodland D.C., Lee K., Bhagat G., et al. Islet grafting and imaging in a bioengineered intramuscular space. Transplantation 2009, 88(9):1065-1074.
15. Pattou F., Kerr-Conte J., Wild D. GLP-1-receptor scanning for imaging of human beta cells transplanted in muscle. N Engl J Med 2010, 363(13):1289-1290.
16. Eich T., Eriksson O., Lundgren T. Visualization of early engraftment in clinical islet transplantation by positron-emission tomography. N Engl J Med 2007, 356(26):2754-2755.
17. Eriksson O., Eich T., Sundin A., Tibell A., Tufveson G., Andersson H., et al. Positron emission tomography in clinical islet transplantation. Am J Transplant 2009, 9(12):2816-2824.
18. Owen R.J., Mercer J.R., Al-Saif F., Molinari M., Ashforth R.A., Rajotte R.V., et al. Portal vein embolization with radiolabeled polyvinyl alcohol particles in a swine model: hepatic distribution and implications for pancreatic islet cell transplantation. Cardiovasc Intervent Radiol 2009, 32(3):499-507.
19. Goto M., Eich T.M., Felldin M., Foss A., Kallen R., Salmela K., et al. Refinement of the automated method for human islet isolation and presentation of a closed system for in vitro islet culture. Transplantation 2004, 78(9):1367-1375.
20. Cabric S., Eich T., Sanchez J., Nilsson B., Korsgren O., Larsson R. A new method for incorporating functional heparin onto the surface of islets of Langerhans. Tissue Eng Part C Methods 2008, 14(2):141-147.
21. Cabric S., Sanchez J., Lundgren T., Foss A., Felldin M., Kallen R., et al. Islet surface heparinization prevents the instant blood-mediated inflammatory reaction in islet transplantation. Diabetes 2007, 56(8):2008-2015.
22. Kett W.C., Osmond R.I., Moe L., Skett S.E., Kinnear B.F., Coombe D.R. Avidin is a heparin-binding protein. Affinity, specificity and structural analysis. Biochim Biophys Acta 2003, 1620(1-3):225-234.
23. Velikyan I., Beyer G.J., Langstrom B. Microwave-supported preparation of (68)Ga bioconjugates with high specific radioactivity. Bioconjug Chem 2004, 15(3):554-560.
24. Nilsson B., Korsgren O., Lambris J.D., Ekdahl K.N. Can cells and biomaterials in therapeutic medicine be shielded from innate immune recognition?. Trends Immunol 2010, 31(1):32-38.
25. Teramura Y., Iwata H. Islet encapsulation with living cells for improvement of biocompatibility. Biomaterials 2009, 30(12):2270-2275.